171 related articles for article (PubMed ID: 38072913)
1. Multi-functionalization of reduced graphene oxide nanosheets for tumor theragnosis: Synthesis, characterization, enzyme assay, in-silico study, radiolabeling and in vivo targeting evaluation.
Sakr TM; Elsabagh MF; Fayez H; Sarhan MO; Syam YM; Anwar MM; Motaleb MA; Zaghary WA
Daru; 2024 Jun; 32(1):77-95. PubMed ID: 38072913
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel chrysin derivatives as poly(ADP-ribose) polymerase 1 (PARP1) inhibitors for the treatment of breast cancer.
Yang Y; Tong J; Xie X; Cao H; Fu Y; Luo Y; Liu S; Chen W; Yang N
Chin J Nat Med; 2024 May; 22(5):455-465. PubMed ID: 38796218
[TBL] [Abstract][Full Text] [Related]
3. The Distribution and Imaging of
Fan G; Wan R; Zhang B; Deng S; Peng M; Xue W; Xu L; Qin X; Wu Y
Cancer Biother Radiopharm; 2018 Dec; 33(10):445-459. PubMed ID: 30133308
[No Abstract] [Full Text] [Related]
4. A novel
Shamsel-Din HA; Gizawy MA; Zaki EG; Elgendy A
J Labelled Comp Radiopharm; 2020 Jun; 63(8):376-385. PubMed ID: 32335935
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
6.
Bayoumi NA; Emam AN
Int J Radiat Biol; 2021; 97(7):977-985. PubMed ID: 33900891
[TBL] [Abstract][Full Text] [Related]
7. Iron oxide nanoparticulate system as a cornerstone in the effective delivery of Tc-99 m radionuclide: a potential molecular imaging probe for tumor diagnosis.
Swidan MM; Khowessah OM; El-Motaleb MA; El-Bary AA; El-Kolaly MT; Sakr TM
Daru; 2019 Jun; 27(1):49-58. PubMed ID: 30706223
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model.
Jiao H; Zhao X; Liu J; Ma T; Zhang Z; Zhang J; Wang J
Nucl Med Biol; 2019; 68-69():31-39. PubMed ID: 30578135
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of (99m)Tc-EDTA-MN and Its Bioimaging in Mouse].
Qi Y; Li G; Chi X; Du L; Huang K; Zhang H; Huang B
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):422-6. PubMed ID: 26182867
[TBL] [Abstract][Full Text] [Related]
10. Breast Tumor Targeting with PAMAM-PEG-5FU-
Narmani A; Arani MAA; Mohammadnejad J; Vaziri AZ; Solymani S; Yavari K; Talebi F; Darzi SJ
Biomed Microdevices; 2020 Apr; 22(2):31. PubMed ID: 32335724
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting.
Kim WH; Kim CG; Kim MH; Kim DW; Park CR; Park JY; Lee YS; Youn H; Kang KW; Jeong JM; Chung JK
Ann Nucl Med; 2016 Jun; 30(5):369-79. PubMed ID: 26993818
[TBL] [Abstract][Full Text] [Related]
12. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
Wang L; Shi J; Kim YS; Zhai S; Jia B; Zhao H; Liu Z; Wang F; Chen X; Liu S
Mol Pharm; 2009; 6(1):231-45. PubMed ID: 19067525
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Radiolabeling of Glu-Urea-Lys with
Hatamabadi D; Joukar S; Shakeri P; Balalaie S; Yazdani A; Khoramjouy M; Mazidi SM; Kobarfard F; Mosayebnia M; Bozorgchami N; Ahmadi M; Ayyoubzadeh SM; Shahhosseini S
Cancer Biother Radiopharm; 2023 Sep; 38(7):486-496. PubMed ID: 37578479
[No Abstract] [Full Text] [Related]
14. Amelioration of Tumor Targeting and In Vivo Biodistribution of
El-Safoury DM; Ibrahim AB; El-Setouhy DA; Khowessah OM; Motaleb MA; Sakr TM
J Pharm Sci; 2021 Aug; 110(8):2955-2965. PubMed ID: 33812886
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preclinical evaluation of rhenium and technetium-99m "4 + 1" mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents.
Kiritsis C; Shegani A; Makrypidi K; Roupa I; Lazopoulos A; Panagiotopoulou A; Triantopoulou S; Paravatou-Petsotas M; Pietzsch HJ; Pelecanou M; Papadopoulos M; Pirmettis I
Bioorg Med Chem; 2022 Nov; 73():117012. PubMed ID: 36155319
[TBL] [Abstract][Full Text] [Related]
16. The effect of ligand density on in vivo tumor targeting of nanographene oxide.
Lee JH; Sahu A; Jang C; Tae G
J Control Release; 2015 Jul; 209():219-28. PubMed ID: 25937319
[TBL] [Abstract][Full Text] [Related]
17. Preparation and
Okarvi SM; Aljammaz I
Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
[TBL] [Abstract][Full Text] [Related]
18. [In vivo imaging of breast tumors by a
Kang L; Huo Y; Wang RF; Zhang CL; Yan P; Xu XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):326-330. PubMed ID: 29643534
[TBL] [Abstract][Full Text] [Related]
19. Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes.
De Silva L; Fu JY; Htar TT; Muniyandy S; Kasbollah A; Wan Kamal WHB; Chuah LH
Int J Nanomedicine; 2019; 14():1101-1117. PubMed ID: 30863048
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.
Chen Y; Su Y; Pang X; Song X; Zhao W; Yu M
Front Oncol; 2022; 12():869260. PubMed ID: 35530359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
